Grown Rogue International Inc. (GRIN.CN)
CAD 0.66
(-1.49%)
CAD 0.66
(-1.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.61 Million USD | 137.04% |
| 2022 | 7.43 Million USD | 4.85% |
| 2021 | 7.08 Million USD | 50.49% |
| 2020 | 4.7 Million USD | 8.01% |
| 2019 | 4.36 Million USD | -22.33% |
| 2018 | 5.61 Million USD | 1237.52% |
| 2017 | 419.72 Thousand USD | -53.17% |
| 2016 | 896.23 Thousand USD | -64.32% |
| 2015 | 2.51 Million USD | -65.93% |
| 2014 | 7.37 Million USD | 14.7% |
| 2013 | 6.42 Million USD | 5.54% |
| 2012 | 6.08 Million USD | 13.39% |
| 2011 | 5.37 Million USD | 204.95% |
| 2010 | 1.76 Million USD | 426.81% |
| 2009 | 334.33 Thousand USD | 17.73% |
| 2008 | 283.98 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 27.02 Million USD | 15.75% |
| 2024 Q2 | 23.34 Million USD | 0.0% |
| 2023 FY | 17.61 Million USD | 137.04% |
| 2023 Q4 | 17.61 Million USD | 5.7% |
| 2023 Q2 | 9.09 Million USD | -1.05% |
| 2023 Q1 | 9.19 Million USD | 23.74% |
| 2023 Q3 | 16.66 Million USD | 83.16% |
| 2022 Q3 | 7.33 Million USD | -16.35% |
| 2022 Q2 | 8.76 Million USD | 15.19% |
| 2022 Q4 | 7.43 Million USD | 1.32% |
| 2022 FY | 7.43 Million USD | 4.85% |
| 2022 Q1 | 7.61 Million USD | 7.39% |
| 2021 Q2 | 3.75 Million USD | -48.3% |
| 2021 Q1 | 7.26 Million USD | 54.21% |
| 2021 Q4 | 7.08 Million USD | 40.38% |
| 2021 FY | 7.08 Million USD | 50.49% |
| 2021 Q3 | 5.04 Million USD | 34.45% |
| 2020 FY | 4.7 Million USD | 8.01% |
| 2020 Q1 | 4.77 Million USD | 9.49% |
| 2020 Q2 | 5.13 Million USD | 7.58% |
| 2020 Q3 | 4.7 Million USD | -8.36% |
| 2020 Q4 | 4.7 Million USD | 0.07% |
| 2019 Q3 | 4.02 Million USD | 19.29% |
| 2019 Q4 | 4.36 Million USD | 8.38% |
| 2019 Q1 | 3.04 Million USD | -45.77% |
| 2019 FY | 4.36 Million USD | -22.33% |
| 2019 Q2 | 3.37 Million USD | 10.78% |
| 2018 Q3 | 641.1 Thousand USD | 15.79% |
| 2018 FY | 5.61 Million USD | 1237.52% |
| 2018 Q4 | 5.61 Million USD | 775.66% |
| 2018 Q2 | 553.69 Thousand USD | 11.59% |
| 2018 Q1 | 496.19 Thousand USD | 4.06% |
| 2017 FY | 419.72 Thousand USD | -53.17% |
| 2017 Q3 | 419.72 Thousand USD | -62.53% |
| 2017 Q4 | 476.84 Thousand USD | 13.61% |
| 2017 Q2 | 1.12 Million USD | 12.7% |
| 2017 Q1 | 993.85 Thousand USD | 3.38% |
| 2016 Q3 | 896.23 Thousand USD | 335.11% |
| 2016 Q1 | 126.47 Thousand USD | -81.11% |
| 2016 FY | 896.23 Thousand USD | -64.32% |
| 2016 Q2 | 205.97 Thousand USD | 62.86% |
| 2016 Q4 | 961.37 Thousand USD | 7.27% |
| 2015 Q3 | 2.51 Million USD | -64.68% |
| 2015 FY | 2.51 Million USD | -65.93% |
| 2015 Q1 | 6.72 Million USD | -10.41% |
| 2015 Q2 | 7.11 Million USD | 5.83% |
| 2015 Q4 | 669.53 Thousand USD | -73.35% |
| 2014 Q3 | 7.37 Million USD | 28.04% |
| 2014 Q2 | 5.75 Million USD | -8.61% |
| 2014 Q1 | 6.3 Million USD | -2.3% |
| 2014 FY | 7.37 Million USD | 14.7% |
| 2014 Q4 | 7.5 Million USD | 1.75% |
| 2013 Q4 | 6.44 Million USD | 0.33% |
| 2013 FY | 6.42 Million USD | 5.54% |
| 2013 Q1 | 6.78 Million USD | 1.04% |
| 2013 Q2 | 6.82 Million USD | 0.58% |
| 2013 Q3 | 6.42 Million USD | -5.84% |
| 2012 Q2 | 5.42 Million USD | 8.08% |
| 2012 Q1 | 5.01 Million USD | -13.16% |
| 2012 Q4 | 6.71 Million USD | 10.3% |
| 2012 Q3 | 6.08 Million USD | 12.25% |
| 2012 FY | 6.08 Million USD | 13.39% |
| 2011 Q1 | 4.2 Million USD | 11.69% |
| 2011 Q2 | 4.36 Million USD | 3.63% |
| 2011 Q4 | 5.78 Million USD | 7.63% |
| 2011 Q3 | 5.37 Million USD | 23.15% |
| 2011 FY | 5.37 Million USD | 204.95% |
| 2010 FY | 1.76 Million USD | 426.81% |
| 2010 Q4 | 3.76 Million USD | 113.93% |
| 2010 Q3 | 1.76 Million USD | 479.83% |
| 2010 Q2 | 303.75 Thousand USD | 3.23% |
| 2010 Q1 | 294.25 Thousand USD | -8.41% |
| 2009 FY | 334.33 Thousand USD | 17.73% |
| 2009 Q3 | 305.25 Thousand USD | 0.0% |
| 2009 Q4 | 321.28 Thousand USD | 5.25% |
| 2008 FY | 283.98 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | -499.839% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | -23.013% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -3641.96% |
| The BC Bud Corporation | 626 Thousand CAD | -2713.763% |
| BioNxt Solutions Inc. | 6.55 Million CAD | -168.911% |
| CordovaCann Corp. | 11.29 Million CAD | -56.004% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | -107.202% |
| Captor Capital Corp. | 28.76 Million CAD | 38.764% |
| City View Green Holdings Inc. | 3.73 Million CAD | -371.856% |
| 1CM Inc. | 9.42 Million CAD | -86.915% |
| Global Hemp Group Inc. | 5.82 Million CAD | -202.383% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 16.812% |
| IM Cannabis Corp. | 35.11 Million CAD | 49.835% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -616.138% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | -74.728% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -6727.236% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | -300.019% |
| Ovation Science Inc. | 728.99 Thousand CAD | -2316.25% |
| Pharmadrug Inc. | 2.92 Million CAD | -502.1% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -743.21% |
| RAMM Pharma Corp. | 2.83 Million CAD | -521.203% |
| RIV Capital Inc. | 275.63 Million CAD | 93.61% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | -417.468% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 95.169% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 53.132% |
| 1933 Industries Inc. | 23.28 Million CAD | 24.347% |
| Red Light Holland Corp. | 3.82 Million CAD | -360.906% |
| Top Strike Resources Corp. | 20.99 Million CAD | 16.099% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -2129.781% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 0.246% |